Cargando…
Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer
It is relevant to find new prognostic and diagnostic biomarkers for endometrial cancer. The study group consisted of 94 cases of endometrial cancer, the control group of 65 cases of normal endometrium. We evaluated PON1 and PTX3 serum levels. The ROC curve was plotted. The area under the curve was c...
Autores principales: | Kozłowski, Mateusz, Michalczyk, Kaja, Witczak, Grzegorz, Kwiatkowski, Sebastian, Mirecka, Aneta, Nowak, Katarzyna, Pius-Sadowska, Ewa, Machaliński, Bogusław, Cymbaluk-Płoska, Aneta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598697/ https://www.ncbi.nlm.nih.gov/pubmed/36290747 http://dx.doi.org/10.3390/antiox11102024 |
Ejemplares similares
-
Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020) -
Could Vaspin Be a Potential Diagnostic Marker in Endometrial Cancer?
por: Pietrzyk, Dominika, et al.
Publicado: (2023) -
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020) -
Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022) -
Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022)